Antibodies to Ro-52 have been shown to be present with anti-Ro-60 (with or without co-existing anti-La) at a high frequency in sera from patients with systemic lupus erythematosus (SLE) and SS [4,5] and one area of interest has centred on their possible pathogenic role in the development of congenital heart block, a complication of the neonatal lupus syndrome [6]. Here, TRIM21 is linked to synovial sarcoma.